Isolated Severe Neutropenia in Adults, Evaluation of Underlying Causes and Outcomes, Real-World Data Collected over a 5-Year Period in a Tertiary Referral Hospital.

Autor: Njue L; Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Porret N; Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Schnegg-Kaufmann AS; Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Varra LF; IDSC-Insel Data Science Centre, 3010 Bern, Switzerland., Andres M; Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Rovó A; Department of Hematology and Central Hematological Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.

Publikováno v: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 Sep 26; Vol. 60 (10). Date of Electronic Publication: 2024 Sep 26.

Effect of MAPK activation via mutations in NRAS, KRAS and BRAF on clinical outcome in newly diagnosed multiple myeloma.

Autor: Perroud C; Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital of Bern, Bern, Switzerland.; Department of Internal Medicine, Hôpital Cantonal Fribourgeois HFR, Fribourg, Switzerland., Thurian D; Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital of Bern, Bern, Switzerland.; Department of Internal Medicine, Spital Thun STS AG, Thun, Switzerland., Andres M; Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital of Bern, Bern, Switzerland., Künzi A; Clinical Trials Unit, University of Bern, Bern, Switzerland., Wiedemann G; Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital of Bern, Bern, Switzerland., Zeerleder S; Department of Hematology, Kantonsspital Luzern and University of Bern, Luzern, Switzerland., Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital of Bern, Bern, Switzerland., Pabst T; Department of Clinical Oncology, Inselspital, University Hospital of Bern, Bern, Switzerland., Banz Y; Institute of Pathology, University of Bern, Bern, Switzerland., Porret N; Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital of Bern, Bern, Switzerland., Rebmann E; Department of Hematology and Central Hematology Laboratory, Inselspital, University Hospital of Bern, Bern, Switzerland.; Department of Oncology-Hematology, Hospital of Neuchâtel (RHNe), Neuchâtel, Switzerland.

Publikováno v: Hematological oncology [Hematol Oncol] 2023 Dec; Vol. 41 (5), pp. 912-921. Date of Electronic Publication: 2023 Jul 15.

Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma

Autor: Messerli C; University Hospital and University of Bern, Department of Medical Oncology, Bern, Switzerland, Wiedemann G; University Hospital and University of Bern, Department of Hematology and Central Hematology Laboratory, Bern, Switzerland, Porret N; University Hospital and University of Bern, Department of Hematology and Central Hematology Laboratory, Bern, Switzerland, Nagler M; University Institute of Clinical Chemistry, University Hospital and University of Bern, Bern, Switzerland, Seipel K; University of Bern, Department for Biomedical Research, Bern, Switzerland, Jeker B; University Hospital and University of Bern, Department of Medical Oncology, Bern, Switzerland, Novak U; University Hospital and University of Bern, Department of Medical Oncology, Bern, Switzerland, Zeerleder S; University Hospital and University of Bern, Department of Hematology and Central Hematology Laboratory, Bern, Switzerland, Bacher U; University Hospital and University of Bern, Department of Hematology and Central Hematology Laboratory, Bern, Switzerland, Pabst T; University Hospital and University of Bern, Department of Medical Oncology, Bern, Switzerland

Publikováno v: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 Aug 31; Vol. 40 (3), pp. 187-196. Date of Electronic Publication: 2023 Jul 31.

CAR T-Cell Persistence Correlates with Improved Outcome in Patients with B-Cell Lymphoma.

Autor: Wittibschlager V; Department of Medical Oncology, Inselspital, University Hospital of Bern, 3010 Bern, Switzerland., Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Seipel K; Department of Medical Oncology, Inselspital, University Hospital of Bern, 3010 Bern, Switzerland., Porret N; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Wiedemann G; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Haslebacher C; Department of Medical Oncology, Inselspital, University Hospital of Bern, 3010 Bern, Switzerland., Hoffmann M; Department of Medical Oncology, Inselspital, University Hospital of Bern, 3010 Bern, Switzerland., Daskalakis M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland., Akhoundova D; Department of Medical Oncology, Inselspital, University Hospital of Bern, 3010 Bern, Switzerland., Pabst T; Department of Medical Oncology, Inselspital, University Hospital of Bern, 3010 Bern, Switzerland.; Center of Hemato-Oncology, University Cancer Center, 3010 Bern, Switzerland.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 16; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 16.

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma.

Autor: Heini AD; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Porret N; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Wiedemann G; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Legros M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Stalder Zeerleder D; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Seipel K; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Daskalakis M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.

Publikováno v: Cells [Cells] 2022 Sep 02; Vol. 11 (17). Date of Electronic Publication: 2022 Sep 02.